Literature DB >> 19288293

Bronchoprovocation testing.

Chakravarthy Reddy1.   

Abstract

Airway smooth muscles of asthmatics tend to be hyperresponsive when provoked. The exaggerated bronchial constriction can be measured by the airflow limitation seen following bronchial provocation. Measuring bronchial hyperresponsiveness by broncho provocation testing is helpful in diagnosing and optimizing therapy. While numerous agents have been used to provoke a measurable airflow limitation, standardized protocols are available for only a few. This article aims to discuss the various methods that have been reported for bronchoprovocation testing.

Entities:  

Mesh：

Year:  2009        PMID： 19288293     DOI： 10.1007/s12016-009-8126-1

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


  44 in total

1.  Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5' monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze.

Authors:  l J Doull; D Sandall; S Smith; J Schreiber; N J Freezer; S T Holgate
Journal:  Pediatr Pulmonol       Date:  1997-06

2.  Difference between dosimeter and tidal breathing methacholine challenge: contributions of dose and deep inspiration bronchoprotection.

Authors:  Nathan D Allen; Beth E Davis; Thomas S Hurst; Donald W Cockcroft
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

Review 3.  Exercise-induced asthma: update on pathophysiology, clinical diagnosis, and treatment.

Authors:  C Randolph
Journal:  Curr Probl Pediatr       Date:  1997-02

4.  Evaluation of bronchial responsiveness by pharmacological challenges in asthma. Inhaled propranolol in comparison with histamine and methacholine.

Authors:  A Chetta; A Foresi; G Garavaldi; G M Corbo; A Cuomo; D Olivieri
Journal:  Respiration       Date:  1988       Impact factor: 3.580

5.  Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics.

Authors:  E F Juniper; P A Kline; M A Vanzieleghem; E H Ramsdale; P M O'Byrne; F E Hargreave
Journal:  Am Rev Respir Dis       Date:  1990-10

6.  Diagnostic value of the bronchial provocation test with methacholine in asthma. A Bayesian analysis approach.

Authors:  M Perpiñá; C Pellicer; A de Diego; L Compte; V Macián
Journal:  Chest       Date:  1993-07       Impact factor: 9.410

7.  A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects.

Authors:  M Chatham; E R Bleecker; P L Smith; R R Rosenthal; P Mason; P S Norman
Journal:  Am Rev Respir Dis       Date:  1982-08

8.  Bronchial response to nebulized antibiotics in children with cystic fibrosis.

Authors:  H L Chua; G G Collis; P N Le Souëf
Journal:  Eur Respir J       Date:  1990-11       Impact factor: 16.671

9.  Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine.

Authors:  M van den Berge; H A Kerstjens; R J Meijer; D M de Reus; G H Koëter; H F Kauffman; D S Postma
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

10.  The determinants of airway hyperresponsiveness to hypertonic saline in atopic asthma in vivo. Relationship with sub-populations of peripheral blood leucocytes.

Authors:  J K Sont; P Booms; E H Bel; J P Vandenbroucke; P J Sterk
Journal:  Clin Exp Allergy       Date:  1993-08       Impact factor: 5.018
View more
  3 in total

1.  Fluctuation analysis of respiratory impedance waveform in asthmatic patients: effect of airway obstruction.

Authors:  J Veiga; A J Lopes; J M Jansen; P L Melo
Journal:  Med Biol Eng Comput       Date:  2012-09-27       Impact factor: 2.602

2.  Novel challenges for the allergist.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

3.  Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.

Authors:  Roland Arnitz; Markus Stein; Petra Bauer; Barbara Lanthaler; Herbert Jamnig; Sabine Scholl-Bürgi; Katharina Stempfl-Al-Jazrawi; Hanno Ulmer; Bernhard Baumgartner; Sabine Embacher; Simon Geisler; Johanna M Gostner; Bernhard Müllinger; Beate Kälz; Markus Nagl
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.